Delivery Order SPE2DB22D3004-SPE2DB24FPJ72
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order worth $1,741.62 by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, with a completion date of February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen Drug Corp and DLA, which serves as the primary contract vehicle for...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,641.94 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. The delivery order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,483.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The delivery order is set to be completed by February 22, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver a comprehensive range of pharmaceutical products and...
- Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML pharmaceutical product. The $3,744.16 contract has a completion date of February 7, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $12,092.39 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML pharmaceutical products. This order has a completion date of February 2, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a range of...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The contract, valued at $1,208.65, has a performance period through January 26, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,741.62 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract with a potential value of $1,741.62 by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The potential value of this contract is $1,741.62, with a completion date of February 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $6,966.48 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPJ72Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a Firm Fixed Price Delivery Order by the Defense Logistics Agency (DLA) to provide the pharmaceutical product OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The award has a potential value of $1,161.08 and a performance period through February 21, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/20/24 |